Your session is about to expire
← Back to Search
Genetic-Guided Pharmacologic Therapy for High Blood Pressure (PGEN for HTN Trial)
PGEN for HTN Trial Summary
This trial is looking at whether or not using genetic information to guide blood pressure therapy can help improve treatment and decrease the time to blood pressure control.
PGEN for HTN Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PGEN for HTN Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have high blood pressure caused by another medical condition.Your kidney disease has been diagnosed by a blood test that shows high creatinine levels.You are between 30 and 80 years old.Your liver is not working properly, as determined by specific lab test results or diagnosed liver disease.You have been diagnosed with serious heart problems like coronary artery disease, heart failure, or congenital heart disease.You have been diagnosed with significant blood vessel disease in your arms, legs, or lungs.You have a history of hormone-related conditions, except for mild type 2 diabetes and well-managed hypothyroidism.You have recently been diagnosed with high blood pressure or have high blood pressure that is not well controlled with one medication.You have a body mass index (BMI) between 19 and 50.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- Group 1: JNC-8-Guided Treatment
- Group 2: Genetically-Guided Treatment for HTN
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
Is there an elevated risk for those using the Geneticure Panel to treat hypertension?
"Because there is only evidence supporting its safety, Geneticure Panel for HTN therapy was rated a 2 on our 1 to 3 scale. This is reflective of the Phase 2 status of this clinical trial as efficacy data has yet to be collected."
Is there a specific demographic of individuals who would be eligible to join this experiment?
"This trial is seeking to include 1000 hypertensive individuals, aged between 30 and 80."
How many healthcare centers are conducting this experiment in the city?
"Fifteen different medical sites have been selected to enroll patients in this clinical trial, with Lino Lakes, Burnsville and Zimmerman being among the cities that are participating. To reduce any travel burden related to participation, it is beneficial for potential participants to select a location nearest them."
Is this experiment recruiting geriatric patients?
"This trial is seeking participants between 30 and 80 years old. For those under 18, there are 54 trials available while 661 exist for individuals over 65."
Is recruitment for this experiment presently underway?
"Clinicaltrials.gov indicates that this medical trial, which was initially posted on June 1st 2022 and last edited two months later, has ceased recruitment of participants. However, many other clinical trials are currently searching for patients - a total of 747 studies in fact!"
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger